Re: Clinical Outcomes of cT1 Micropapillary Bladder Cancer: D. L. Willis, M. I. Fernandez, R. J. Dickstein, S. Parikh, J. B. Shah, L. L. Pisters, C. C. Guo, S. Henderson, B. A. Czerniak, H. B. Grossman, C. P. Dinney and A. M. Kamat J Urol 2015;193:1129-1134.
Department of Urology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
Indraneel
I
Banerjee
Department of Urology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
Suresh
S
Yadav
Department of Urology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
Shivam
S
Priyadarshi
Department of Urology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
Vinay
V
Tomar
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002291:Carcinoma, Papillary / Q000188:drug therapy* / Q000601:surgery*; D015653:Cystectomy; D005260:Female; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine